GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.71 Cr | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.71 Cr |
| Mar2024 | ₹3.73 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹4.00 Cr |
| Mar2021 | ₹3.88 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.71 Cr | 26.36 | |
| Mar2024 | ₹3.73 Cr | -7.56 | |
| Mar2023 | ₹4.03 Cr | 0.98 | |
| Mar2022 | ₹4.00 Cr | 3.10 | |
| Mar2021 | ₹3.88 Cr | - | |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,891.8 Cr | -8.2% | -8.8% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -8.2% |
-8.8% |
24.3% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses